Currently, clinical risk factors for metastasis in patients with PCC/PGLs include tumor location, genotype, and size.[12] Patients with SDHB-related PCC/PGLs, extra-adrenal tumors or a primary tumor size over 5 cm have a higher risk to develop metastatic disease. Here, SDHB is linked to adrenal gland pheochromocytoma.